Coronavirus
Merck on path to bring COVID treatment pill to Japan
Japanese pharma sector works on own coronavirus drug candidates
Pharmaceuticals
Coronavirus
Merck seeks first U.S. authorization for COVID-19 pill
Oral antiviral drug to treat mild-to-moderate patients can be taken at home
Pharmaceuticals
WHO backs world's first malaria vaccine for Africa's children
GlaxoSmithKline's Mosquirix could offer big breakthrough against deadly disease
COVID vaccines
COVID nasal spray vaccine set to enter clinical trial in Japan
Shionogi's inoculation method to help emerging nations lacking medical staff
Coronavirus
From Pfizer to Shionogi, drugmakers race for coronavirus pills
Oral treatments crucial to beating pandemic enter late-stage trials
COVID vaccines
Vietnam's homemade vaccines struggle to debut as COVID rages
Front-runner Nanocovax asked to evaluate efficacy
COVID vaccines
India jabs 22m in single day as it races to vaccinate all adults
Nation must maintain pace of 10m shots a day to reach December goal
COVID vaccines
World to have 12bn COVID vaccine doses by year-end, but redistribution key
G-7 holds big surpluses of shots while developing nations lack access, report says
Health Care
Brain-stimulating glasses to fight dementia, Japanese companies say
Drugmaker Sumitomo Dainippon Pharma aims to start clinical trials in two years
Pharmaceuticals
Thai demand for medicinal herb surges as natural COVID treatment
Government grants fah talai jone stamp of approval in bid to boost rural support
COVID vaccines
Moderna finds stainless steel particles in shots pulled in Japan
US drugmaker and distributor Takeda say no undue risk to public
COVID vaccines
India to roll out DNA-based COVID shots for teens in October
120m adolescents await first-of-their-kind needle-free vaccine doses
Pharmaceuticals
Eisai-Biogen Alzheimer's drug off to slow US start amid controversy
Major hospitals steer clear as questions persist about effectiveness
COVID vaccines
Moderna's contaminated jab only shipped to Japan: Spanish maker
Detection of 'particulate matter' in vials led Japan to suspend 1.6m doses
COVID vaccines
1.6m Moderna doses withdrawn in Japan over contamination
Company confirms reports of particulate matter in vials, but finds 'no safety issues'
COVID vaccines
US regulators give full approval to Pfizer-BioNTech vaccine
Pentagon says it will press ahead with plans to require jabs for military personnel
Pharmaceuticals
Eisai-Biogen Alzheimer's drug set for use at 300-plus US hospitals: exec
Head of Japanese drugmaker's neurology division bullish on pricey Aduhelm
Coronavirus
Thailand scrambles for COVID-19 antiviral as vaccines run short
Bangkok to import more Favipiravir as patient numbers surge
COVID vaccines
Moderna says COVID-19 shot still highly effective after 6 months
Drugmaker expects booster to be needed this winter as delta variant poses threat
COVID vaccines
WHO calls on rich nations to halt COVID vaccine boosters
Tedros warns of widening jab gap between wealthy and poor countries
